Epidemiology of Obesity

Publikation: Bidrag til bog/antologi/rapportBidrag til bog/antologiForskning

Obesity is in theory defined on the basis of the excess health risk caused by adiposity exceeding the size normally found in the population, but for practical reasons, the World Health Organization (WHO) has defined obesity as a body mass index (weight (kg)/height (m) 2) of 30 or above for adults. WHO considers the steep increases in prevalence of obesity in all age groups, especially since the 1970s as a global obesity epidemic. Today, approximately 650 million adult people and approximately 340 million children and adolescence (5-19 years) suffer from obesity. It is generally more prevalent among women and older age groups than among men and younger age groups. Beyond the necessity of availability of food, evidence about causes of obesity is still very limited. However, studies have shown that obesity 'runs in families', where both genetics and environmental, and especially social, factors play important roles. Obesity is associated with an increased risk of many adverse medical, mental and social consequences, including a strong relation to type 2 diabetes. Type 2 diabetes and related metabolic syndrome and diseases are major contributors to the excess morbidity and mortality associated with obesity.

OriginalsprogEngelsk
TitelHandbook of Experimental Pharmacology
Redaktører Juergen Eckel , Karine Clément
Antal sider25
UdgivelsesstedHeidelberg
ForlagSpringer
Publikationsdato2022
Udgave1
Sider3-27
ISBN (Elektronisk)978-3-030-99995-7
DOI
StatusUdgivet - 2022
NavnHandbook of Experimental Pharmacology
ISSN0171-2004

Bibliografisk note

© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.

ID: 303685371